Normal weight individuals who develop Type 2 diabetes: The personal fat threshold

Clinical Science

Volumn 128, Issue 7, 2015, Pages 405-410

  Taylor, Roy ^a   Holman, Rury R ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Aetiology; Obesity; Pathogenesis; Type 2 diabetes; Weight loss

Indexed keywords

C PEPTIDE; GLUCOSE;

ARTICLE; BLOOD GLUCOSE MONITORING; BODY FAT; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; DIABETIC OBESITY; DIET RESTRICTION; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PERSONAL FAT THRESHOLD; POPULATION; PRIORITY JOURNAL; REMISSION; UNITED KINGDOM; WEIGHT REDUCTION; ADIPOSE TISSUE; BODY FAT DISTRIBUTION; METABOLISM; OBESITY; PHYSIOLOGY; RISK FACTOR;

ADIPOSE TISSUE; BODY FAT DISTRIBUTION; BODY MASS INDEX; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; RISK FACTORS; WEIGHT LOSS;

EID: 84925284118     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20140553     Document Type: Article

References (50)

1. Turner, R. C. and Holman, R. R. (1976) Insulin rather than glucose homoeostasis in the pathophysiology of diabetes. Lancet i, 1272-1274
2. Holman, R. R. and Turner, R. C. (1979) Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes. Diabetes 28, 227-230
3. Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. and Peto, J. (1979) Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 28, 1086-1096
4. Eckel, R. H., Kahn, S. E., Ferrannini, E., Goldfine, A. B., Nathan, D. M., Schwartz, M. W., Smith, R. J. and Smith, S. R., Endocrine Society, American Diabetes Association and European Association for the Study of Diabetes (2011) Obesity and type 2 diabetes: what can be unified and what needs to be individualized? Diabetes Care 34, 1424-1430
5. Vaag, A. and Lund, S. S. (2007) Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention? Appl. Physiol. Nutr. Metab. 32, 912-920
6. Jarrett, R. J., Keen, H., Fuller, J. H. and McCartney, M. (1979) Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes"). Diabetologia 16, 25-30
7. Taylor, R. (1989) Aetiology of non-insulin dependent diabetes. Br. Med. Bull. 45, 73-91
8. Leslie, R. D. G. and Pyke, D. A. (1985) Genetics of Diabetes. The Diabetes Annual/1 (Alberti, K. G. M. M. and Krall, L. P., eds), pp. 53-66, Elsevier Science Publishers, Amsterdam
9. Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A. and Butler, P. C. (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102-110
10. Ostenson, C. G. and Efendic, S. (2007) Islet gene expression and function in type 2 diabetes; studies in the Goto-Kakizaki rat and humans. Diabetes Obes. Metab. 9 Suppl. 2, 180-186
11. Hinnouho, G. M., Czernichow, S., Dugravot, A., Batty, G. D., Kivimaki, M. and Singh-Manoux, A. (2013) Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care 36, 2294-2300
12. Hollenbeck, C. B., Chen, Y. D. and Reaven, G. M. (1984) A comparison of the relative effects of obesity and non-insulin dependent diabetes mellitus on in vivo insulin stimulated glucose utilization. Diabetes 33, 622-626
13. Juhl, C. B., Bradley, U., Holst, J. J., Leslie, R. D., Yderstraede, K. B. and Hunter, S. (2014) Similar weight-adjusted insulin secretion and insulin sensitivity in short-duration late autoimmune diabetes of adulthood (LADA) and type 2 diabetes: Action LADA 8. Diabet. Med. 38, 941-945
14. McCarthy, S. T., Harris, E. and Turner, R. C. (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13, 93-97
15. Turner, R. C., McCarthy, S. T., Holman, R. R. and Harris, E. (1976) Beta-cell function improved by supplementing basal insulin secretion in mild diabetes. Br. Med. J. 1, 1252-1254
16. Reaven, G. M., Chen, Y. D., Hollenbeck, C. B., Sheu, W. H., Ostrega, D. and Polonsky, K. S. (1993) Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J. Clin. Endocrinol. Metab. 76, 44-48
17. Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R. and Matthews, D. R. (2012) Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55, 1577-1596
18. Bi, Y., Tong, G. Y., Yang, H. J., Cai, M. Y., Ma, J. H., Liang, J., Xin, B., Miao, H., Peng, Z. H. and Zhu, D. L. (2013) The beneficial effect of metformin on β-cell function in non-obese Chinese subjects with newly diagnosed type 2 diabetes. Diabetes Metab. Res. Rev. 29, 664-672
19. Ito, H., Ishida, H., Takeuchi, Y., Antoku, S., Abe, M., Mifune, M. and Togane, M. (2010) Long-term effect of metformin on blood glucose control in non-obese patients with type 2 diabetes mellitus. Nutr. Metab. 7, 83
20. UKPDS. (1991) UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia 34, 877-890
21. Rosenbaum, S., Skinner, R. K., Knight, I. B. and Garrow, J. S. (1985) A survey of heights and weights of adults in Great Britain, 1980. Ann. Hum. Biol. 12, 115-127
22. Hrdlicka, A. (1908) Physiological and medical observations amongs the Indians of southwestern United States and north Mexico. In: Smithsonian Institute BoAE, Government Printing Office, Washington, D.C.
23. Joslin, E. P. (1940) The universality of diabetes: a survey of diabetes mortality in Arizona. JAMA 115, 2033-2038
24. Knowler, W. C., Pettitt, D. J., Savage, P. J. and Bennett, P. H. (1981) Diabetes incidence in Pima indians: contributions of obesity and parental diabetes. Am. J. Epidemiol. 113, 144-156
25. Schulz, L. O., Bennett, P. H., Ravussin, E., Kidd, J. R., Kidd, K. K., Esparza, J. and Valencia, M. E. (2006) Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S. Diabetes Care 29, 1866-1871
26. O'Rahilly, S. and Farooqi, I. S. (2008) Human obesity: a heritable neurobehavioral disorder that is highly sensitive to environmental conditions. Diabetes 57, 2905-2910
27. Franco, M., Bilal, U., Orduñez, P., Benet, M., Morejón, A., Caballero, B., Kennelly, J. F. and Cooper, R. S. (2013) Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparison of secular trends. BMJ 346, f1515
28. Himsworth, H. P. (1949) Diet in the etiology of human diabetes. Proc. Roy. Soc. Med. 42, 323-326
29. Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G. and Willett, W. C. (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N. Engl. J. Med. 345, 790-797
30. Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C. and Taylor, R. (2011) Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54, 2506-2514
31. Taylor, R. (2013) Type 2 diabetes: etiology and reversibility. Diabetes Care 36, 1047-1055
32. Gregg, E. W., Chen, H., Wagenknecht, L. E., Clark, J. M., Delahanty, L. M., Bantle, J., Pownall, H. J., Johnson, K. C., Safford, M. M., Kitabchi, A. E. et al. (2012) Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308, 2489-2496
33. Henry, R. R., Wallace, P. and Olefsky, J. M. (1986) Effects of weight loss on mechanisms of hyperglycaemia in obese non-insulin dependent diabetes mellitus. Diabetes 35, 990-998
34. UKPDS (1990) UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic paitents, UKPDS group. Metabolism 39, 905-912
35. Steven, S., Lim, E. and Taylor, R. (2013) Population response to information on reversibility of type 2 diabetes. Diabet. Med. 30, e135-e138
36. Doughty, R. (2013) Type 2 diabetes and the diet that cured me. The Guardian, 12 May 2013 http://www.theguardian.com/lifeandstyle/2013/may/12/type-2-diabetes-diet-cure
37. Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H. and Dobbins, R. L. (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am. J. Physiol. Endocrinol. Metab. 288, E462-E468
38. Perry, R. J., Samuel, V. T., Petersen, K. F. and Shulman, G. I. (2014) The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 510, 84-91
39. Kantartzis, K., Peter, A., Machicao, F., Machann, J., Wagner, S., Königsrainer, I., Königsrainer, A., Schick, F., Fritsche, A., Häring, H. U. and Stefan, N. (2009) Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 58, 2616-2623
40. Szczepaniak, L. S., Victor, R. G., Mathur, R., Nelson, M. D., Szczepaniak, E. W., Tyer, N., Chen, I., Unger, R. H., Bergman, R. N. and Lingvay, I. (2012) Pancreatic steatosis and its relationship to β-cell dysfunction in humans: racial and ethnic variations. Diabetes Care 35, 2377-2383
41. Lee, Y., Hirose, H., Ohneda, M., Johnson, J. H., McGarry, J. D. and Unger, R. H. (1994) Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc. Natl. Acad. Sci. U. S. A. 91, 10878-10882
42. Kantartzis, K., Machann, J., Schick, F., Fritsche, A., Häring, H. U. and Stefan, N. (2010) The impact of liver fat vs visceral fat in determining categories of prediabetes. Diabetologia 53, 882-889
43. Fabbrini, E., Magkos, F., Mohammed, B. S., Pietka, T., Abumrad, N. A., Patterson, B. W., Okunade, A. and Klein, S. (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc. Natl. Acad. Sci. U. S. A. 106, 15430-15435
44. Tillin, T., Sattar, N., Godsland, I. F., Hughes, A. D., Chaturvedi, N. and Forouhi, N. G. (2014) Ethnicity-specific obesity cut-points in the development of type 2 diabetes - a prospective study including three ethnic groups in the United Kingdom. Diabet. Med. doi: 10.1111/dme.12576
45. Farrell, G. C., Wong, V. W. and Chitturi, S. (2013) NAFLD in Asia-as common and important as in the West. Nat. Rev. Gastroenterol. Hepatol. 10, 307-318
46. Khoo, C. M., Leow, M. K., Sadananthan, S. A., Lim, R., Venkataraman, K., Khoo, E. Y., Velan, S. S., Ong, Y. T., Kambadur, R., McFarlane, C. et al. (2014) Body fat partitioning does not explain the interethnic variation in insulin sensitivity among Asian ethnicity: the Singapore adults metabolism study. Diabetes 63, 1093-1102
47. Shibata, M., Kihara, Y., Taguchi, M., Tashiro, M. and Otsuki, M. (2007) Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 30, 2940-2944
48. McGarry, J. D. (2002) Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51, 7-18
49. Unger, R. H. (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44, 863-870
50. Storgaard, H., Jensen, C. B., Vaag, A. A., Vølund, A. and Madsbad, S. (2003) Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetes. Metabolism 52, 885-894